While allogeneic human umbilical cord-derived mesenchymal stem cells (UC-MSCs) treatment efficiently promoted megakaryocytic lineage differentiation of CML cells through restoring the MPL expression and activating MPL signaling. The gene discussed is MPL; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.